Peer Review History
| Original SubmissionJanuary 21, 2026 |
|---|
|
-->PONE-D-26-03707-->-->Genome-wide characterization of copy number variants and their functional relevance in indigenous draught cattle of South Asia-->-->PLOS One Dear Dr. Periasamy, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 31 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Tofazzal Md Rakib, PhD Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “International Atomic Energy Agency Technical cooperation projects KAM5009, SRL5046 and MYA5022.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Partly ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: No ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: No ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: The manuscript's topic is of interest. The study provides valuable insights into the genome-wide characterization of copy number variation regions (CNVRs) in eight indigenous Asian zebu cattle, traditionally used for ploughing, wet-field agriculture, and carting. Several genes overlapping these CNVRs were associated with immune function, metabolism, and adaptation, and some regions corresponded to QTLs linked to carcass, fertility, reproduction, and growth traits. The findings provide important genomic resources for understanding structural variation and support cattle breeding and conservation programs. Overall, the manuscript is well-structured, and the findings are supported by vigorous data analysis. Minor revision • Introduction lines 100-128, the examples of breeds are lengthy. Consider shortening these examples to make the introduction more concise. • Lines 153–155: “eight distinct breeds was performed with five samples per breed: Kangayam, Hallikar, Bargur and Deoni from India, White Cattle from Sri Lanka, Kdarm Red from Cambodia, Pyar Sein and Shwe Ni cattle from Myanmar” could be presented in a table format (e.g., breed name, country of origin, and number of samples). This would make the information easier to read. Reviewer #2: This manuscript presents a genome-wide characterization of copy number variation regions across eight indigenous South Asian zebu cattle breeds using read-depth-based approaches, followed by analyses of population differentiation, functional annotation, and QTL overlap. The topic is relevant, and the dataset has value, particularly because structural variation remains undercharacterized in many indigenous cattle populations. The use of two CNV callers, genome-wide cataloging, and downstream functional analyses provides a potentially useful baseline resource. Overall, I find the study technically sound, with an acceptable methodology but limited biological depth and consistent overinterpretation of results. The study is suitable for publication after major revision. My main concerns center on methodological justification, reporting clarity, and overinterpretation of the biological significance of the results. In particular, the CNV detection framework is broadly reasonable but requires additional explanation in several places; the population differentiation results are modest and should be interpreted more cautiously; the Hallikar-specific findings need stronger support; and the enrichment/QTL sections currently read as overly descriptive and more speculative than the data warrant. Below are my specific major comments Introduction: • At lines 68-78, the discussion of CNVs, their size range, mechanisms of origin, and effects on gene expression should be more fully referenced. • The section around lines 90-94 and 100-109 also needs supporting citations, especially where the manuscript summarizes the major computational approaches for CNV detection and their advantages. • The breed descriptions at lines 105-120 could also be improved. A concise breed reference may be sufficient in the main text, while more detailed breed descriptions or representative photos could be moved to the Supplementary Information if the authors wish to provide additional context. • 132-134, The manuscript would benefit from a more focused introduction that clearly summarizes what is currently known about CNVs in Asian zebu cattle. This should include key findings from previous studies, commonly used methodologies, and any existing limitations in the literature. In addition, the authors should explicitly define the specific gap this study addresses and the new insights it aims to provide. Clarifying this will help the reader better understand the motivation and the precise contribution of the work. Materials and methods: • At lines 155–159, the manuscript should provide more explicit information about the source of the DNA samples, how genomic DNA was extracted or processed, and the sequencing design. It is also important to state whether the reads were single-end or paired-end, their read length, and the target or achieved sequencing depth per sample. These details are necessary for reproducibility and for evaluating the suitability of the data for read-depth–based CNV calling. • The use of CNVnator and CNVcaller is a reasonable approach for CNV discovery from short-read data. However, several aspects of the methodology here still need clarification and justification. For instance, at lines 179–180, the authors should justify the use of a 100 bp bin size in CNVnator. This choice increases nominal resolution but can also increase susceptibility to local coverage noise. It would also be helpful to know whether alternative bin sizes were considered and why 100 bp was ultimately selected. • At lines 195–197, the generation of custom duplicated window files and a custom reference setup for CNVcaller introduces reproducibility concerns. The authors should describe more clearly how this resource was generated and validated, and ideally make the pipeline or script publicly available. • At lines 201–205, the CNVcaller filters -f 0.1 and -h 3 may bias the analysis toward common CNVs while excluding low-frequency or truly breed-specific events. This is particularly relevant because the manuscript later interprets the biological significance of shared versus breed-specific CNVRs. The authors should discuss how these thresholds may influence the observed CNVR spectrum and whether they reduce sensitivity to rare variants. • At line 204, the use of a 50% reciprocal overlap criterion for merging CNVs into CNVRs should be explicitly justified. This is a common heuristic, but it remains an arbitrary threshold that can affect the number and size of CNVRs. If possible, a brief sensitivity check or rationale would strengthen the methodological rigor. Results: • At line 236, the reported sequencing metrics, including mean coverage around 21.2× and mapping rate around 99%, indicate good overall data quality and support the use of read-depth–based CNV detection in this dataset. However, the manuscript’s wording that this enables “accurate CNV detection” is somewhat too strong given the known limitations of read-depth methods, especially in repetitive or low-mappability regions. A more cautious phrasing would be appropriate. • At lines 244–245, the statement that CNVs were retained based on “p-value < 0.01 based on t-test statistics” requires more detail. CNVnator reports multiple p-value-related metrics, and it is currently unclear which statistic the authors used. The manuscript should clarify which CNVnator p-value output was applied, how that p-value is defined within CNVnator, and whether any multiple-testing considerations were taken into account. The wording should also make clear that this is part of CNVnator’s internal model rather than a separate test performed independently by the authors. • At lines 251–259, the manuscript reports that CNVRs cover approximately 6.23% of the autosomal genome. This should be contextualized against previous cattle CNV studies. The authors should also clarify whether repetitive regions or segmental duplications were filtered or masked, as this may substantially affect apparent CNVR coverage. • The reported mean CNVR length of about 27 kb, together with the statement that many CNVRs are under 5 kb, suggests a skewed size distribution. It would be more informative to provide the median CNVR size. • The comparison of CNVR counts across chromosomes should be normalized by chromosome length, as larger chromosomes are expected to harbor more CNVs. Without normalization, these comparisons are difficult to interpret. • At lines 260–276, the manuscript interprets pairwise VST values across breeds. The use of VST is appropriate for CNV-based population differentiation, but the observed values indicate predominantly low to modest differentiation. Most pairwise comparisons are below 0.02, and even the highest value, around 0.084, is more consistent with moderate than “pronounced” differentiation. The language used in this section should therefore be toned down. • In addition, statements that differentiation is “driven by region-specific CNVRs” are not directly demonstrated by the current analysis, because the manuscript does not present a locus-level analysis of the CNVRs contributing most strongly to VST. The authors should contextualize the observed VST range relative to other CNV studies, avoid overinterpreting modest values, and, if possible, identify specific high-VST CNVRs. A comparison with SNP-based population structure, if such data are available, would also strengthen interpretation. • At lines 278–293, the manuscript reports a striking excess of breed-specific CNVRs in Hallikar relative to the other breeds. This is potentially interesting, but the degree of skew requires additional scrutiny. It is not clear whether this pattern reflects genuine biological divergence or whether it may be influenced by other factors. The authors should provide more support for this observation. • The definition of “breed-specific” CNVRs should also be interpreted cautiously. The absence of detection in other breeds is not equivalent to a confirmed biological absence, especially in CNV analyses based on short-read read depth. Furthermore, statements linking Hallikar-specific CNVRs to local adaptation or selection are currently speculative and should be presented with greater caution unless stronger functional or population-genetic evidence is provided. The discussion should also explicitly note that CNVcaller filtering parameters may bias results toward shared CNVRs while reducing the detection of rare variants. • Relating to lines 294-348, the author should specify the background gene set used in ShinyGO and clarify what is qualified as a gene “overlap” with a CNVR, because CNVRs can be large and overlap multiple genes. The analysis is also vulnerable to region-size bias, which should be acknowledged. • Moreover, the interpretation of the enrichment results is too strong. Broad categories such as immune regulation, metabolism, neuronal signaling, stress response, and endocrine pathways are common outputs in genome-wide enrichment analyses and do not by themselves constitute evidence for draught performance, endurance, thermotolerance, temperament, or adaptive energy utilization. Several statements in the current Results section go beyond what the data support by implying functional causality or phenotype-level inference from general enrichment results alone. • The same caution applies to the QTL overlap analysis. Reporting overlap with QTL intervals can be useful as exploratory context, but the current manuscript does not establish whether the observed overlaps exceed chance expectation. The biological interpretation of these overlaps should be framed as hypothesis-generating rather than confirmatory. This is especially important for the Hallikar-specific CNVRs, where the number of events is relatively small but the interpretation is still expansive. • Importantly, I strongly encourage the authors to shorten this section, focus on the most credible and biologically plausible candidate genes or pathways, clearly separate statistical enrichment from functional inference, and substantially tone down causal language. Discussion • At lines 382–414, parts of the discussion read more like background material and may be more appropriate in the introduction. The discussion would be stronger if it focused more directly on what this dataset adds relative to prior reports. • At lines 402–404, if the study is framed as expanding previous datasets or knowledge, the discussion should explicitly state what is concordant with prior work and what is new here. • At lines 415–418, the restatement of the number of CNVs and CNVRs is clear, but the discussion should move beyond repeating results and instead interpret the implications more critically. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
-->PONE-D-26-03707R1-->-->Genome-wide characterization of copy number variants and their functional relevance in indigenous draught cattle of South Asia-->-->PLOS One Dear Dr. Periasamy, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> ==============================-->-->Academic Editor Comments: -->--> 1. Please deposit the custom scripts/workflows used for generating the CNVcaller duplicated-window files and reference database in a public repository and provide the repository URL. In addition, please include the repository link within the Data Availability Statement and associate URL of the BioProject accession.-->-->2. Please provide a sensitivity analysis (preferably as Supplementary Material) demonstrating the effect of different overlap thresholds on CNVR detection and the stability of the main conclusions.-->-->3. The substantially higher number of Hallikar-specific CNVRs warrants additional validation. Please provide evidence that this observation is not attributable to differences in sequencing depth, data quality, or CNV calling/filtering procedures.-->-->4. Please provide complete details of the enrichment analysis, including the background gene set, annotation source/version, and significance thresholds used. ==============================-->--> Please submit your revised manuscript by Aug 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
--> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Tofazzal Md Rakib, PhD Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: (No Response) ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> |
| Revision 2 |
|
Genome-wide characterization of copy number variants and their functional relevance in indigenous draught cattle of South Asia PONE-D-26-03707R2 Dear Dr. Periasamy, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tofazzal Md Rakib, PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-26-03707R2 PLOS One Dear Dr. Periasamy, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tofazzal Md Rakib Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .